nevirapine and bedaquiline

nevirapine has been researched along with bedaquiline in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dooley, KE; Karlsson, MO; Svensson, EM1
Conradie, F; Hughes, J; Maartens, G; McIlleron, H; Pandie, M; Siwendu, S; Variava, E; Wiesner, L1
Brill, MJ; Karlsson, MO; Maartens, G; Pandie, M; Svensson, EM1
Daftary, A; Dooley, KE; Friedland, G; O'Donnell, MR; Orrell, C; Padayatchi, N; Rivet Amico, K1

Trials

1 trial(s) available for nevirapine and bedaquiline

ArticleYear
Impact of lopinavir-ritonavir or nevirapine on bedaquiline exposures and potential implications for patients with tuberculosis-HIV coinfection.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Combinations; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Middle Aged; Mycobacterium tuberculosis; Nevirapine; Ritonavir; Tuberculosis; Young Adult

2014

Other Studies

3 other study(ies) available for nevirapine and bedaquiline

ArticleYear
Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:4

    Topics: Adult; Antitubercular Agents; Diarylquinolines; Drug Combinations; Drug Interactions; Drug Monitoring; Female; HIV Infections; Humans; Lopinavir; Male; Nevirapine; Ritonavir; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult

2016
Confirming model-predicted pharmacokinetic interactions between bedaquiline and lopinavir/ritonavir or nevirapine in patients with HIV and drug-resistant tuberculosis.
    International journal of antimicrobial agents, 2017, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Antitubercular Agents; Diarylquinolines; Drug Interactions; Female; HIV Infections; Humans; Lopinavir; Male; Middle Aged; Nevirapine; Ritonavir; Tuberculosis, Multidrug-Resistant; Young Adult

2017
Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection.
    The lancet. HIV, 2019, Volume: 6, Issue:3

    Topics: Anti-Retroviral Agents; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Substitution; Female; HIV Infections; Humans; Male; Medication Adherence; Nevirapine; South Africa; Tuberculosis, Multidrug-Resistant

2019